BCBA/JNJ (BCBA/JNJ)

Buenos Aires Stock Exchange: BCBA/JNJ · ARS

ARS 29,680

-161.14 (-0.5%)· Recorded snapshot

Market cap	995.1T
Revenue (ttm)	151.3T
Net income (ttm)	24.5T
EPS (ttm)	ARS 675
P/E (trailing)	44.0x
P/E (forward)	23.8x
Dividend	ARS 363 (1.22%)
Volume	6,821
Beta	0.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 151.3T
Net income (ttm): 24.5T
EPS (ttm): ARS 675
P/E (trailing): 44.0x
P/E (forward): 23.8x
Market cap: 995.1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E23.8

P25 n/aP50 n/aP75 n/a

Trailing P/E44

P25 n/aP50 n/aP75 n/a

ROE20

P25 n/aP50 n/aP75 n/a

ROIC21.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/JNJ indicators

Market & fundamental data

Available fields

259

Groups with data

Currency

USD

Showing 259 of 259 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-13
Employees	138,200
Employees change	6,200
Employees growth	4.7%
Enterprise value	ARS 1037.3T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-27
First seen	2026-05-10
Fiscal year end	December
Founded	1886
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT110236
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Last stock split date	2022-11-17
Last stock split type	Forward
Market cap	ARS 995.1T
Next earnings date	2027-01-19
Price	ARS 29,680.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/JNJ
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	46.5x
Average P/E ratio (3Y)	20.72x
Average P/E ratio (5Y)	22.21x
Earnings yield	2.28%
EV/Earnings	42.3x
EV/EBIT	25.53x
EV/EBITDA	19.43x
EV/FCF	33.07x
EV/Sales	6.79x
FCF / EV yield	3.02%
FCF yield	3.15%
Forward P/E	23.84x
Graham number	7807.96999
Graham upside	-73.69%
Lynch fair value	ARS 3,656.84
Lynch upside	-87.68%
P/(FCF - SBC) ratio	34.08x
P/(OCF - SBC) ratio	26.41x
P/B ratio	8.01x
P/E ratio	43.95x
P/FCF ratio	31.72x
P/OCF ratio	24.97x
P/S ratio	6.58x
Price/EBITDA ratio	18.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.59%
EBITDA margin	34.73%
Effective tax rate	9.26%
FCF margin	20.53%
Gross margin	67.77%
Operating margin	26.59%
Pretax margin	17.86%
Profit margin	16.2%
Profit per employee	ARS 177.4M
Profitable quarters	14
Profitable years	35
Revenue per employee	ARS 1.1B
ROA	8.46%
ROA (5Y)	8.04%
ROCE	18.6%
ROE	20.02%
ROE (5Y)	24.21%
ROIC	21.57%
ROIC (5Y)	23.67%
SBC / revenue	1.43%
Tax / revenue	1.65%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-36.37%
EPS growth (Q)	-95.89%
EPS growth (QoQ)	-96.16%
EPS growth 10Y	1.46%
EPS growth 3Y	-20.75%
EPS growth 5Y	-0.32%
EPS growth years	1
FCF growth	5.07%
FCF growth (Q)	-20.64%
FCF growth (QoQ)	-12.84%
FCF growth 3Y	9.37%
FCF growth 5Y	-1.72%
Gross profit growth	6.88%
Gross profit growth (Q)	3.56%
Gross profit growth 3Y	5.04%
Gross profit growth 5Y	1.75%
Net income growth	-35.93%
Net income growth (Q)	-95.92%
Net income growth (QoQ)	-96.21%
Net income growth 3Y	-22.54%
Net income growth 5Y	-2.08%
Net income growth years	1
OCF growth	8.08%
OCF growth (Q)	-15.8%
OCF growth (QoQ)	-10.4%
OCF growth 10Y	4.28%
OCF growth 3Y	8.86%
OCF growth 5Y	0.11%
Operating income growth	7.65%
Operating income growth (Q)	-9.78%
Operating income growth 3Y	3.06%
Operating income growth 5Y	1.65%
Revenue growth	7.8%
Revenue growth (Q)	5.86%
Revenue growth (QoQ)	0.35%
Revenue growth 10Y	3.33%
Revenue growth 3Y	5.87%
Revenue growth 5Y	1.67%
Revenue growth quarters	13
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -8.5T
Depreciation and amortization	ARS 12.4T
EBIT	ARS 40.2T
EBITDA	ARS 52.6T
EPS	ARS 675.25
Financing cash flow	ARS -27.7T
Free cash flow	ARS 31.4T
Free cash flow minus SBC	ARS 29.2T
Gross profit	ARS 102.6T
Income taxes	ARS 2.5T
Investing cash flow	ARS -14.2T
Net borrowing	ARS -1.2T
Net cash flow	ARS -2T
Net income	ARS 24.5T
Operating cash flow minus SBC	ARS 37.7T
Operating income	ARS 40.2T
Revenue	ARS 151.3T
Stock-based compensation	ARS 2.2T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.03
Book value per share	ARS 51,600.89
Debt / EBITDA	1.29
Debt / equity	0.55
Debt / FCF	2.17
Goodwill	ARS 74.6T
Interest coverage	26.84
Long-term assets	ARS 214.1T
Long-term liabilities	ARS 91.3T
Net cash (debt)	ARS -41.8T
Net cash / market cap	-4.2%
Net debt / EBITDA	0.79
Net debt / equity	0.34
Net debt / FCF	1.33
Piotroski F-Score	6
Property, plant and equipment	ARS 37.1T
Shareholders' equity	ARS 124.2T
Tangible book value	ARS -20.7T
Tangible book value per share	ARS -8,605.74
Total assets	ARS 300.8T
Total cash	ARS 26.2T
Total debt	ARS 68T
Total liabilities	ARS 176.6T
WACC	5.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	ARS 86.7T
Current liabilities	ARS 85.3T
Current ratio	1.02
Inventory turnover	2.17
Net working capital	ARS -11.4T
Quick ratio	0.65
Working capital	ARS 1.4T
Working capital turnover	65,287.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.8%
Dividend growth	17.81%
Dividend growth (10Y)	7.28%
Dividend growth (3Y)	8.67%
Dividend growth (5Y)	8.66%
Dividend growth years	24
Dividend payment date	2026-12-09
Dividend payment years	29
Dividend payout frequency	Quarterly
Dividend per share	ARS 363.41
Dividend yield	1.22%
Ex-dividend date	2026-11-24
Last dividend	ARS 0.09
Payout ratio	79.01%
Shareholder yield	0.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	25,195.53%
10Y return CAGR	76.28%
10Y total return	28,850.11%
150-day SMA	ARS 25,844.40
15Y price change	147,436.91%
15Y return CAGR	64.9%
15Y total return	181,145%
1D price change	-0.54%
1M price change	1.23%
1M total return	1.23%
1W price change	7.85%
1W total return	7.85%
1Y price change	49.37%
1Y return CAGR	51.71%
1Y total return	51.67%
20-day SMA	ARS 28,105.00
200-day SMA	ARS 25,147.30
20Y price change	211,401.46%
20Y return CAGR	48.85%
20Y total return	284,844.21%
3M price change	5.77%
3M total return	6.26%
3Y price change	240.86%
3Y return CAGR	52.91%
3Y total return	257.63%
50-day SMA	ARS 28,522.40
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 30,340.00
52-week high date	2026-10-26
52-week low	ARS 17,010.00
52-week low date	2025-10-27
5Y price change	1,235.13%
5Y return CAGR	70.13%
5Y total return	1,324.67%
6M price change	30.46%
6M total return	31.53%
All-time high	ARS 30,340.00
All-time high date	2026-10-26
All-time low	ARS 3.10
All-time low date	2001-04-26
Average true range (ATR)	ARS 766.54
Average volume	14.5K
Beta (5Y)	0.21
Change from 52-week high	-2.18%
Change from 52-week low	74.49%
Change from all-time high	-2.18%
Change from all-time low	957,319.35%
Change from open	-0.4%
Day's gap	-0.13%
Dollar volume	ARS 202.4M
High price	ARS 29,840.00
Low price	ARS 29,420.00
Monthly RSI	82.93
Open price	ARS 29,800.00
Position in 52-week range	61.9%
Previous close	ARS 29,840.00
Price vs 150-day SMA	14.84%
Price vs 20-day SMA	5.6%
Price vs 200-day SMA	18.02%
Price vs 50-day SMA	4.06%
Relative volume	0.47
RSI	61.64
Sharpe ratio	1.81
Sharpe ratio (3Y)	1.39
Sharpe ratio (5Y)	1.74
Sortino ratio	2.97
Sortino ratio (3Y)	2.36
Sortino ratio (5Y)	2.97
Volume	6.8K
Weekly RSI	65.58
YTD price change	41.13%
YTD total return	42.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.4B
Shares change (QoQ)	0.35%
Shares change (YoY)	0.8%
Shares held by insiders	0.04%
Shares held by institutions	76.32%
Short ratio	2.4 days

Deeper analysis on BCBA/JNJ

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/JNJ report

Is a complete BCBA/JNJ research report available?

No complete published report is available for bcba/JNJ (BCBA/JNJ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/JNJ (BCBA/JNJ)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/JNJ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/JNJ indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/JNJ

Frequently asked questions